Author

@Investinc_Intel Investinc_Intel

High-conviction retail growth holder championing a tight basket of unloved AI-leveraged names

Posts concentrated, narrative-driven fundamental bull theses

trader score
+0.69
hit rate
70%
mean α
+0.58%
signals 14d
184

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 70% hit rate, +0.58% mean alpha, trader score +0.69. Their last-14d mentions, direction-adjusted, have moved -0.9% since posting (mean over 169 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-28ZETA@Investinc_Intel+0.55Describes a new ZETA patent for dynamic AI model and tool selection.
2026-08-28·@Investinc_Intel·Rocket emoji expresses bullish expectations for Monday's stock market.·
2026-08-28SOFI@Investinc_Intel-0.30States that markets are pricing a rate hike, with SOFI highlighted in the chart.
2026-08-28IREN@Investinc_Intel+0.30Compares IREN's leveraged AI-infrastructure growth with HIMS's capital-efficient model.
2026-08-28HIMS@Investinc_Intel+0.50Compares IREN's leveraged AI-infrastructure growth with HIMS's capital-efficient model.
2026-08-28HIMS@Investinc_Intel+0.72Plans to load the HIMS position meaningfully if price reaches $24-$25. — Explicit forward plan to add heavily at a specified entry range.
2026-08-28NOW@Investinc_Intel+0.00Reports ZETA outperforming NOW by 30% since NOW's bottom.
2026-08-28ZETA@Investinc_Intel+0.60Reports ZETA outperforming NOW by 30% since NOW's bottom.
2026-08-28SOFI@Investinc_Intel-0.20Reports hike odds at 43% after Jackson Hole and SOFI falling on the news.
2026-08-28NBIS@Investinc_Intel+0.62Bullish Neocloud rotation thesis based on rising contract pricing and compute scarcity.
2026-08-28IREN@Investinc_Intel+0.72Bullish Neocloud rotation thesis based on rising contract pricing and compute scarcity.
2026-08-28CRWV@Investinc_Intel+0.62Bullish Neocloud rotation thesis based on rising contract pricing and compute scarcity.
2026-08-28HIMS@Investinc_Intel+0.75Strongly praises HIMS's peptide launch via a flagship-product analogy.
2026-08-27HIMS@Investinc_Intel-0.25Fifth Circuit upheld FDA removal of major GLP-1 drugs from the shortage list, limiting mass compounding paths.-8.9%
2026-08-27SOFI@Investinc_Intel+0.45Reports SOFI's highest closing price since April 20.-5.8%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.